These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 34254844)

  • 1. Chemical Modifications of the Capsid for Redirecting and Improving the Efficacy of Adeno-Associated Virus Vectors.
    Lam AK; Frabutt D; Li L; Xiao W
    Hum Gene Ther; 2021 Dec; 32(23-24):1433-1438. PubMed ID: 34254844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical approaches to probe and engineer AAV vectors.
    Pham Q; Glicksman J; Chatterjee A
    Nanoscale; 2024 Jul; 16(29):13820-13833. PubMed ID: 38978480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic Engineering of AAV Capsid Gene for Gene Therapy Application.
    Liu Y; Zhang X; Yang L
    Curr Gene Ther; 2020; 20(5):321-332. PubMed ID: 32998676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SUMOylation Targets Adeno-associated Virus Capsids but Mainly Restricts Transduction by Cellular Mechanisms.
    Chen Q; Njenga R; Leuchs B; Chiocca S; Kleinschmidt J; Müller M
    J Virol; 2020 Sep; 94(19):. PubMed ID: 32669341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ocular Inflammatory Response to Intravitreal Injection of Adeno-Associated Virus Vector: Relative Contribution of Genome and Capsid.
    Timmers AM; Newmark JA; Turunen HT; Farivar T; Liu J; Song C; Ye GJ; Pennock S; Gaskin C; Knop DR; Shearman MS
    Hum Gene Ther; 2020 Jan; 31(1-2):80-89. PubMed ID: 31544533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Boosters for adeno-associated virus (AAV) vector (r)evolution.
    Szumska J; Grimm D
    Cytotherapy; 2023 Mar; 25(3):254-260. PubMed ID: 35999132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small But Increasingly Mighty: Latest Advances in AAV Vector Research, Design, and Evolution.
    Grimm D; Büning H
    Hum Gene Ther; 2017 Nov; 28(11):1075-1086. PubMed ID: 28835125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Machine-learning-guided Directed Evolution for AAV Capsid Engineering.
    Fu X; Suo H; Zhang J; Chen D
    Curr Pharm Des; 2024; 30(11):811-824. PubMed ID: 38445704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adeno-associated virus (AAV) capsid engineering in liver-directed gene therapy.
    Rodríguez-Márquez E; Meumann N; Büning H
    Expert Opin Biol Ther; 2021 Jun; 21(6):749-766. PubMed ID: 33331201
    [No Abstract]   [Full Text] [Related]  

  • 10. Coevolution of Adeno-associated Virus Capsid Antigenicity and Tropism through a Structure-Guided Approach.
    Havlik LP; Simon KE; Smith JK; Klinc KA; Tse LV; Oh DK; Fanous MM; Meganck RM; Mietzsch M; Kleinschmidt J; Agbandje-McKenna M; Asokan A
    J Virol; 2020 Sep; 94(19):. PubMed ID: 32669336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemical modification of AAV9 capsid with N-ethyl maleimide alters vector tissue tropism.
    Mulcrone PL; Lam AK; Frabutt D; Zhang J; Chrzanowski M; Herzog RW; Xiao W
    Sci Rep; 2023 May; 13(1):8436. PubMed ID: 37231038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vector Affinity and Receptor Distribution Define Tissue-Specific Targeting in an Engineered AAV Capsid.
    Martino RA; Wang Q; Xu H; Hu G; Bell P; Arroyo EJ; Sims JJ; Wilson JM
    J Virol; 2023 Jun; 97(6):e0017423. PubMed ID: 37199615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Redirecting AAV vectors to extrahepatic tissues.
    Asokan A; Shen S
    Mol Ther; 2023 Dec; 31(12):3371-3375. PubMed ID: 37805712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-translational modifications in capsid proteins of recombinant adeno-associated virus (AAV) 1-rh10 serotypes.
    Mary B; Maurya S; Arumugam S; Kumar V; Jayandharan GR
    FEBS J; 2019 Dec; 286(24):4964-4981. PubMed ID: 31330090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tracking Adeno-Associated Virus Capsid Evolution by High-Throughput Sequencing.
    de Alencastro G; Pekrun K; Valdmanis P; Tiffany M; Xu J; Kay MA
    Hum Gene Ther; 2020 May; 31(9-10):553-564. PubMed ID: 32024384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Context-Specific Function of the Engineered Peptide Domain of PHP.B.
    Martino RA; Fluck EC; Murphy J; Wang Q; Hoff H; Pumroy RA; Lee CY; Sims JJ; Roy S; Moiseenkova-Bell VY; Wilson JM
    J Virol; 2021 Sep; 95(20):e0116421. PubMed ID: 34346767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Site-Specific Post-translational Surface Modification of Adeno-Associated Virus Vectors Using Leucine Zippers.
    Thadani NN; Yang J; Moyo B; Lee CM; Chen MY; Bao G; Suh J
    ACS Synth Biol; 2020 Mar; 9(3):461-467. PubMed ID: 32068391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adeno-Associated Virus Vector Design-Moving the Adeno-Associated Virus to a Bioengineered Therapeutic Nanoparticle.
    Jäschke N; Büning H
    Hematol Oncol Clin North Am; 2022 Aug; 36(4):667-685. PubMed ID: 35778330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving clinical efficacy of adeno associated vectors by rational capsid bioengineering.
    Sen D
    J Biomed Sci; 2014 Nov; 21(1):103. PubMed ID: 25425174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineering adeno-associated virus vectors for gene therapy.
    Li C; Samulski RJ
    Nat Rev Genet; 2020 Apr; 21(4):255-272. PubMed ID: 32042148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.